){kind=logo}
Viaqua Therapeutics
)
ViAqua develops RNAi-based, species-specific solutions that enhance aquaculture health and productivity by precisely targeting pathogens, delivering a sustainable, residue-free alternative to traditional treatments.
- Number of employees: 9
- HQ: Isreal
- Founded in: 2015
- Backed by: S2G ventures, Rabobank ventures, ICIG ventures, Trendlines, Nutreco
- Looking to engage with: Feed additive, biotech, and animal health companies and investors
)
){kind=logo}
)
)
)